Article info
PDFClinical science
Ophthalmic manifestations of myelin oligodendrocyte glycoprotein-IgG-associated disorder other than optic neuritis: a systematic review
- Correspondence to Jonathan A. Micieli, Kensington Vision and Research Centre, 501-340 College Street, Toronto, Ontario, Canada; jmicieli{at}kensingtonhealth.org
Citation
Ophthalmic manifestations of myelin oligodendrocyte glycoprotein-IgG-associated disorder other than optic neuritis: a systematic review
Publication history
- Received June 24, 2020
- Revised September 5, 2020
- Accepted September 6, 2020
- First published September 30, 2020.
Online issue publication
January 08, 2022
Article Versions
- Previous version (8 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.